SOLOXERA Trademark

Trademark Overview

On Friday, January 8, 2016, a trademark application was filed for SOLOXERA with the United States Patent and Trademark Office. The USPTO has given the SOLOXERA trademark a serial number of 86870002. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 26, 2019. This trademark is owned by Cempra Pharmaceuticals, Inc.. The SOLOXERA trademark is filed in the Pharmaceutical Products category with the following description:

Antibiotics; anti-inflammatories; pharmaceutical preparations for treatment of diabetes; pharmaceutical preparations for treatment of obesity; pharmaceutical preparations for the treatment of liver diseases and disorders
soloxera

General Information

Serial Number86870002
Word MarkSOLOXERA
Filing DateFriday, January 8, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 26, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 31, 2016

Trademark Statements

Goods and ServicesAntibiotics; anti-inflammatories; pharmaceutical preparations for treatment of diabetes; pharmaceutical preparations for treatment of obesity; pharmaceutical preparations for the treatment of liver diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 15, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCempra Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChapel Hill, NC 27517
Party NameCempra Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChapel Hill, NC 27517

Trademark Events

Event DateEvent Description
Monday, August 26, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 26, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 30, 2019EXTENSION 5 GRANTED
Thursday, January 24, 2019EXTENSION 5 FILED
Thursday, January 24, 2019TEAS EXTENSION RECEIVED
Tuesday, July 31, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 31, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, July 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 26, 2018EXTENSION 4 GRANTED
Thursday, July 26, 2018EXTENSION 4 FILED
Thursday, July 26, 2018TEAS EXTENSION RECEIVED
Thursday, March 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 28, 2018EXTENSION 3 GRANTED
Friday, January 26, 2018EXTENSION 3 FILED
Tuesday, February 20, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 9, 2018NOTICE OF REVIVAL - E-MAILED
Friday, February 9, 2018EXTENSION RECEIVED WITH TEAS PETITION
Friday, February 9, 2018PETITION TO REVIVE-GRANTED
Friday, February 9, 2018TEAS PETITION TO REVIVE RECEIVED
Wednesday, June 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 26, 2017EXTENSION 2 GRANTED
Monday, June 26, 2017EXTENSION 2 FILED
Monday, June 26, 2017TEAS EXTENSION RECEIVED
Saturday, January 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 5, 2017EXTENSION 1 GRANTED
Thursday, January 5, 2017EXTENSION 1 FILED
Thursday, January 5, 2017TEAS EXTENSION RECEIVED
Tuesday, July 26, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 31, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2016PUBLISHED FOR OPPOSITION
Wednesday, May 11, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 25, 2016ASSIGNED TO EXAMINER
Friday, January 15, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 12, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

soloxera preparations pharmaceutical treatment liver diseases disorders obesity diabetes anti antibiotics